U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Atropine Sulfate Injection
Status: Currently in Shortage
»Date first posted: 01/01/2012
»Therapeutic Categories: Anesthesia; Neurology; Pediatric

Expand all

Accord Healthcare Inc. (Reverified 07/01/2024)

Company Contact Information:
866-941-7875, option 2

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, .4 mg/1 mL (NDC 16729-525-08) Unavailable Shortage duration not available. Requirements related to complying with good manufacturing practices
Injection, .4 mg/1 mL (NDC 16729-512-43) Unavailable Shortage duration not available. Requirements related to complying with good manufacturing practices
Injection, 1 mg/1 mL (NDC 16729-526-08) Available
Injection, .05 mg/1 mL (NDC 16729-483-03) Unavailable Temporarily discontinued Other
Injection, .1 mg/1 mL (NDC 16729-484-45) Unavailable Inventory on hold pending further assessment Requirements related to complying with good manufacturing practices
Injection, .1 mg/1 mL (NDC 16729-484-90) Unavailable Temporarily discontinued Other

American Regent, Inc. (Reverified 07/01/2024)

Company Contact Information:
800-645-1706

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 1 mg/1 mL (NDC 0517-1001-25) Available old NDC 0517-1010-25
Injection, .4 mg/1 mL (NDC 0517-1004-25) Available old NDC 0517-0401-25

Amphastar Pharmaceuticals, Inc. (Reverified 06/12/2024)

Company Contact Information:
800-423-4136

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, .1 mg/1 mL (NDC 76329-3340-1) Available

Fresenius Kabi USA, LLC (Reverified 06/27/2024)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, .4 mg/1 mL (NDC 63323-580-20) Available Check wholesalers for inventory

Hikma Pharmaceuticals USA, Inc. (Reverified 07/01/2024)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Atropine Sulfate Injection, USP, Injection, 0.4 mg/1 mL (NDC 0641-6251-10) Available

Hospira, Inc., a Pfizer Company (Revised 07/15/2024)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Atropine Sulfate, Injection, 1 mg/10 mL (0.1 mg/mL) Syringes (NDC 0409-1630-10) Available
Atropine Sulfate, Injection, 0.25 mg/5 mL (0.05 mg/mL) Syringes (NDC 0409-9630-05) Available
Atropine Sulfate, Injection, 0.5 mg/5 mL (0.1 mg/mL) Syringes (NDC 0409-4910-34) Unavailable Next Delivery and Estimated Recovery: April 2025 Demand increase for the drug
Atropine Sulfate, Injection, 1 mg/10 mL (0.1 mg/mL) Syringes (NDC 0409-4911-34) Unavailable Next Delivery: October 2024; Estimated Recovery: March 2025 Demand increase for the drug

Medefil, Inc. (Reverified 07/15/2024)

Company Contact Information:
630-682-4600

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Atropine Sulfate, Injection, .1 mg/1 mL (NDC 64253-400-91) Available
Back to Top